Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells

Chengfei Liu, Yezi Zhu, Wei Lou, Yuanyuan Cui, Christopher P Evans, Allen C Gao

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Fingerprint Dive into the research topics of 'Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences